The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.
The technology is intended for U.S. service members but expected to be used widely by civilians.
The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.
The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.
Building Disaster Resilience Through Collaboration
Amae Health Expands to New York City
Hospital for Special Surgery Opens Two New Facilities in New Jersey
Should We Be Testing Toilet Water in Patient Restrooms?
Healthcare Union Petitions for Increased Staff Safety at HCA Florida Hospitals